Call 413.540.1234 to
schedule an appointment
CONCERN/EAP: 413.534.2625
Billing questions? Call: 413.540.1212
CRISIS: 413.733.6661

Mental Disorders
Resources
Basic InformationLookupsLatest News
Non-Stigmatizing Messages Boost Mental Health Services SupportIncreased Prevalence of Depression, Anxiety After CRCGuidance Offered for Improving Mental Health in WorkplaceCommon Gynecologic Condition Linked to Mental Health IssuesGreat Recession of 2008 Triggered More Than Financial WoesGenetic Variations Impacting Empathy Tied to Psych IssuesEarly Periods Tied to Mental Health Issues Into AdulthoodGender Minorities Have Greater Mental Illness, DisabilityPets Provide Support to People With Mental Health ConditionsPets Good Medicine for Those Battling Mental IllsLimited Evidence for Effect of Cranial Electrical StimulationVirtual Reality-Based CBT Beneficial for Psychotic DisordersAutism, Bipolar and Schizophrenia Share Genetic SimilaritiesSubstantial Unmet Need for Mental Health Care for VeteransMental Health Care Access Differs With Race, InsuranceVA Health System Failing on Mental Health Care: ReportSevere Bullying Tied to Mental Health Woes in TeensMore Sought Mental Health Specialty Care in 2008 to 2015'Mountain Madness' Found to Be a Real PsychosisHealth Tip: Stay WellTaking Your Meds? A Digital Pill Can TellFDA OKs First 'Digital Pill' That Lets Doctors Know It's Been TakenIs Too Much Time Online Raising Suicide Risk in Teen Girls?Childhood Spanking Could Heighten Adult Mental Health WoesSurgical Residents Prime Candidates for Stress, Depression, Alcohol AbuseMedical License Questions Sway Doctors' Mental Health HelpAmericans More Open About Mental Health Issues, But Stigma LingersNarrow Networks in ACA Marketplace for Mental HealthHurricanes' Toll on Mental Health Will LingerER Visits for These 3 Health Woes Don't Have to HappenPreventive Psychological, Educational Programs BeneficialPsychosocial Intervention App Feasible in Serious Mental IllnessHealth Tip: Mental Disorders Are CommonNearly 1 in 5 U.S. Adults Has Mental Illness or Drug ProblemHalf of Opioid Prescriptions Go to People With Mental IllnessPsychological Risks Higher in Atopic Dermatitis PatientsSAMHSA: 9.8 Million U.S. Adults Have Serious Mental IllnessNearly 10 Million U.S. Adults Suffer From Mental IllnessSuicide Risk Is High for Psychiatric Patients Long After Discharge From CareStreptococcal Throat Infection Linked to Mental DisordersMental Health Myths Abound in the U.S.U.S. Soldier in Custody Following Slaying of 5 Americans in Iraq
Questions and AnswersLinksBook Reviews
Related Topics

Anxiety Disorders
Bipolar Disorder
Depression: Depression & Related Conditions
Schizophrenia
Eating Disorders
Medications

FDA OKs First 'Digital Pill' That Lets Doctors Know It's Been Taken


HealthDay News
Updated: Nov 14th 2017

new article illustration

TUESDAY, Nov. 14, 2017 (HealthDay News) -- Offering both the promise of better patient compliance with health care, but also fears of a medical "Big Brother," a newly approved "digital pill" allows physicians to track whether or not it's been ingested by patients.

The U.S. Food and Drug Administration has given the nod to Abilify MyCite, for use in patients with schizophrenia, as an add-on treatment for depression, and to help control episodes of either manic or "mixed" episodes for people with bipolar disorder.

As explained in an FDA news release, the pill contains a sensor that communicates with a wearable patch. This patch in turn sends signals to the patients' smartphone, telling them whether or not they've taken the pill, along with the pertinent dates and times.

"Patients can also permit their caregivers and physician to access the information through a web-based portal," the FDA noted -- opening the possibility that others can track a patient's adherence (or lack thereof) to drug therapy.

"Being able to track ingestion of medications prescribed for mental illness may be useful for some patients," Dr. Mitchell Mathis, director of psychiatry products in the FDA's Center for Drug Evaluation and Research, said in the news release. "The FDA supports the development and use of new technology in prescription drugs and is committed to working with companies to understand how technology might benefit patients and prescribers."

Otsuka Pharmaceutical and Proteus Digital Health, which jointly make Abilify MyCite, said in a news release Monday night that the pill is a logical advance in today's high-tech, connected world.

"The time is right for the category of Digital Medicines to be available to appropriate patients with serious mental illness," said Proteus CEO Andrew Thompson. "Consumers already manage important tasks like banking, shopping, and communicating with friends and family by using their smartphones, as they go about their daily lives. With this FDA approval, Otsuka can help enable individuals with serious mental illness to engage with their care team about their treatment plan in a new way."

Noncompliance with medical regimens is a tough problem, especially when it comes to patients with serious mental health issues, such as schizophrenia, depression and bipolar disorder.

According to The New York Times, medical noncompliance costs the United States $100 billion annually, mainly because failure to adhere to treatment leads to sicker patients who often require expensive hospitalization.

But some doctors worry that digital medications could present their own problems, as patients feel "tracked" by medical professionals and others.

"If used improperly, it could foster more mistrust instead of trust," Ameet Sarpatwari, an instructor in medicine at Harvard Medical School, told the Times.

And psychiatrist Dr. Peter Kramer, who wrote "Listening to Prozac," said drugs like Abilify Mycite come with a built-in "tattletale."

A " 'digital drug' sounds like a potentially coercive tool," he told the Times.

The newspaper noted that similar digital drugs are being developed for a range of conditions, including heart disease, stroke, HIV and diabetes.

More information

There's advice on taking your meds as directed at the American Heart Association.